Use of an adrenal hormone-modifying agent

Details for Australian Patent Application No. 2011205290 (hide)

Owner Novartis AG

Inventors Hu, Qi-Ying; Ksander, Gary; Meredith, Erik; Monovich, Lauren G.; Papillon, Julien; Schumacher, Christoph

Agent Davies Collison Cave

Pub. Number AU-A-2011205290

PCT Pub. Number WO2011/088188

Priority 61/294,980 14.01.10 US

Filing date 13 January 2011

Wipo publication date 21 July 2011

International Classifications

A61P 5/00 Drugs for disorders of the endocrine system

A61K 31/4188

A61K 31/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/088188 Priority application(s): WO2011/088188

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011205296-Matching metadata sources using rules for characterizing matches

2011205283-Compounds and methods